SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

Yep its posted:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DAD2 Member Profile
 
Followed By 65
Posts 5,057
Boards Moderated 0
Alias Born 03/11/09
160x600 placeholder
Advertisement
Compugen to Present at Jefferies 2015 Global Healthcare Conference in New York "Business Wire" - 5/28/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/27/2015 8:06:40 AM
Compugen to Hold Analyst and Investor Day in New York "Business Wire" - 5/27/2015 7:00:00 AM
Compugen Ltd. Reports First Quarter 2015 Results "Business Wire" - 5/5/2015 7:40:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/5/2015 7:37:05 AM
Compugen First Quarter 2015 Conference Call Scheduled for Tuesday, May 5, 2015 at 10:00 AM ET "Business Wire" - 4/28/2015 7:00:00 AM
Compugen Research Coverage Started at Jefferies Group (CGEN) "Analyst Ratings Network" - 4/23/2015 4:51:45 AM
Compugen Obtains Rights to Use Biological Systems and Materials from the US National Institutes of Health "Business Wire" - 4/14/2015 7:02:00 AM
Compugen to Present at Two Immuno-Oncology Conferences in April "Business Wire" - 4/6/2015 7:10:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/19/2015 7:12:17 AM
Compugen Announces Planned Relocation of Headquarters to Larger Facilities "Business Wire" - 3/19/2015 7:09:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) "Edgar (US Regulatory)" - 3/12/2015 12:09:39 PM
Compugen to Present at Two Oncology Conferences in March "Business Wire" - 3/2/2015 7:09:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/27/2015 4:08:31 PM
Compugen Expands and Strengthens Business Development Team "Business Wire" - 2/23/2015 7:04:00 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results "Business Wire" - 2/10/2015 7:10:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/10/2015 7:01:33 AM
Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target "Business Wire" - 2/9/2015 7:14:00 AM
Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at 10:00 AM EST "Business Wire" - 2/3/2015 7:09:00 AM
Compugen to Present Cancer Immunotherapy Targets at Two Tumor Immunology Conferences This Month "Business Wire" - 2/2/2015 7:39:00 AM
Compugen Discloses Initial Experimental Results for Predicted Antibody Drug Conjugate Targets "Business Wire" - 1/5/2015 7:14:00 AM
Compugen Enters Immuno-Oncology Research Collaboration with Johns Hopkins University "Business Wire" - 12/18/2014 7:02:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 12/18/2014 7:01:03 AM
Compugen to Present at Oppenheimer 25th Annual Healthcare Conference "Business Wire" - 12/3/2014 7:01:00 AM
Compugen Announces Experimental Confirmation of Additional Methodology for Discovery of Cancer-Related Immune Checkpoints "Business Wire" - 12/2/2014 7:07:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist